Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

35 (1%)

Anticipated shortage:

9 (0%)

Avoided shortage:

19 (1%)

Resolved:

2320 (97%)

2383

Discontinuation Reports

To be discontinued:

3 (2%)

Discontinued:

131 (96%)

Reversed:

2 (1%)

136

466 (18%)

3 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ SITAGLIPTIN-METFORMIN 1000MG 50MG TABLET Resolved 2023-07-17 2023-08-30 198838
SANDOZ SITAGLIPTIN-METFORMIN 850MG 50MG TABLET Resolved 2023-07-17 2023-08-08 198833
SANDOZ SITAGLIPTIN-METFORMIN 500MG 50MG TABLET Resolved 2024-06-25 2024-07-03 231221
SANDOZ SITAGLIPTIN-METFORMIN 500MG 50MG TABLET Resolved 2024-02-26 2024-03-06 220558
SANDOZ SITAGLIPTIN-METFORMIN 500MG 50MG TABLET Resolved 2023-05-25 2023-07-11 193057
SANDOZ SITAGLIPTIN-METFORMIN 1000MG 50MG TABLET Resolved 2024-10-28 2024-11-26 241407
SANDOZ SITAGLIPTIN-METFORMIN 500MG 50MG TABLET Resolved 2023-08-29 2023-09-26 203193
SANDOZ SITAGLIPTIN-METFORMIN 500MG 50MG TABLET Resolved 2023-10-02 2023-10-11 205811
SANDOZ SITAGLIPTIN-METFORMIN XR 500MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2024-07-15 2024-08-21 232912
SANDOZ SITAGLIPTIN-METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2025-10-06 2025-10-20 268605
SANDOZ SITAGLIPTIN-METFORMIN XR 50MG 500MG TABLET (EXTENDED-RELEASE) Resolved 2025-09-29 2025-10-04 268030
SANDOZ SITAGLIPTIN-METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2025-11-17 2025-12-15 272000
SANDOZ SITAGLIPTIN-METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2024-05-21 2024-05-28 228423
SANDOZ SOLIFENACIN 5MG TABLET Resolved 2022-05-04 2022-08-18 159968
SANDOZ SOLIFENACIN 10MG TABLET Resolved 2019-10-29 2020-03-30 97423
SANDOZ SOLIFENACIN 10MG TABLET Resolved 2020-05-11 2020-08-26 114736
SANDOZ SOLIFENACIN 5MG TABLET Resolved 2020-05-11 2020-08-26 114739
SANDOZ SOLIFENACIN 5MG TABLET Resolved 2024-05-21 2024-06-18 228426
SANDOZ SOLIFENACIN 10MG TABLET Resolved 2020-01-08 2020-08-26 102647
SANDOZ SOLIFENACIN 10MG TABLET Resolved 2019-02-18 2019-05-07 76157
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ANGIOMAX 250MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280590
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BORTEZOMIB FOR INJECTION SDZ 3.5MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280595
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265

Showing 1 to 20 of 136